Savara (SVRA) Net Margin (2013 - 2020)

Savara's (SVRA) quarterly Net Margin came in at 1374100.0% in Q4 2020, down 31696.94% on a QoQ basis from 4321.48% in Q3 2020.

Savara (SVRA) Net Margin (2013 - 2020) Analysis & Trends

Savara (SVRA) has 5 years of Net Margin data on file, last reported at 1374100.0% in Q4 2020.

On a quarterly basis, Net Margin changed N/A year-over-year to 1374100.0% in Q4 2020; TTM through Mar 2022 was 4109700.0%, a N/A change from a year earlier, with the FY2020 full-year figure at 19305.45%, changed N/A from the prior year.
Net Margin for Q4 2020 stood at 1374100.0%, down from 4321.48% in the prior quarter.
Over the last five years, Net Margin for SVRA reached as high as 13257.45% in Q2 2017 and fell as low as 1374100.0% in Q4 2020.
Historically, Net Margin has averaged 229876.45% across 3 years, with a median of 4819.25% in 2020.
On a YoY basis, Net Margin climbed as much as 1730977 bps in 2016 and fell as far as 1730977 bps in 2016.
Year by year, Net Margin stood at 1508.75% in 2016, then soared by 979 bps to 13257.45% in 2017, then sank by 10465 bps to 1374100.0% in 2020.
Per Business Quant data, the three most recent Net Margin figures were 1374100.0% in Q4 2020, 4321.48% in Q3 2020, and 13257.45% in Q2 2017.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Net Margin (Qtr)
1	Oculis Holding AG	68,785.72 Bn	68,785.72 Bn	-	-
2	Nanobiotix	1,895.57 Bn	1,895.51 Bn	-	-
3	BeOne Medicines	471.35 Bn	466.56 Bn	1.35 Bn	15.02%
4	NuCana	279.75 Bn	279.75 Bn	-	-
5	Vertex Pharmaceuticals	120.24 Bn	113.00 Bn	2.59 Bn	34.53%
6	Regeneron Pharmaceuticals	67.80 Bn	59.04 Bn	3.31 Bn	20.17%
7	Belite Bio	62.51 Bn	62.51 Bn	-	-
8	Argenx Se	57.38 Bn	57.38 Bn	1.41 Bn	30.33%
9	Revolution Medicines	37.78 Bn	37.78 Bn	-	-
10	Savara	1.24 Bn	1.24 Bn	-	-

Download Data